Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark and Novation today announced that for the first time in the history of the Kleenex® brand, Kimberly-Clark is offering its complete line of hand-hygiene products via an exclusive ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now There are no microchips in Huggies diapers ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the household products stocks, including Kimberly-Clark (NASDAQ:KMB) and its peers. Household products stocks are generally stable ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...